NCT03482362 2025-08-03
EORTC1616
The Netherlands Cancer Institute
Phase 2 Completed
Clinical Trials
8 trialsNCT02892123 2024-11-27
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Jazz Pharmaceuticals
Phase 1 Completed
NCT05238831 2024-01-23
SMMART Adaptive Clinical Treatment (ACT) Trial
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT02465736 2024-01-16
Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308)
Sun Yat-sen University
Phase 3 Unknown
NCT02331251 2018-07-02
Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)
Western Regional Medical Center
Phase 1/2 Terminated
NCT02665702 2016-01-28
Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
Fudan University
Phase 2 Unknown
NCT02188615 2014-07-11
NACRFMIE
Taizhou Hospital
Phase 2 Unknown
NCT00215462 2009-04-28
Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma
Dana-Farber Cancer Institute
Phase 2 Completed